Skip to main content
Future Journal of Pharmaceutical Sciences

Table 2 System suitability results

From: Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR

Parameter

Rilpivirine

Cabotegravir

USP plate count

2079

3852

Tailing factor

1.25

1.18

Resolution

–

7.73

RT

2.050

3.942

Back to article page